Tourmaline Bio CEO Scott Requadt's 2021 pay falls 78% to $748K
Tourmaline Bio reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
Tourmaline Bio reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, three executives at Tourmaline Bio received on average a compensation package of $634K, a 62% decrease compared to previous year.
Average pay of disclosed executives at Tourmaline Bio
Scott Requadt, Chief Executive Officer, received $748K in total, which decreased by 78% compared to 2020. 69% of Requadt's compensation, or $515K, was in salary. Requadt also received $219K in non-equity incentive plan and $13K in other compensation.
Nancy Krieger, Chief Medical Officer, received a compensation package of $591K, which decreased by 46% compared to previous year. 72% of the compensation package, or $425K, was in salary.
Suzanne T. Ildstad, Chief Scientific Officer, earned $562K in 2021, a 16% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2022.